Estimating treatment effects in clinical crossover trials

References

• Jones , BJ and Kenward , MG . 1989 . Design and Analysis of Cross-Over Trials , London : Chapman and Hall .
   Google Scholar
• Senn , SJ . 1993 . Cross-Over Trials in Clinical Research , Chichester and New York : Wiley .
   Google Scholar
• Cushny , AR and Peebles , AR . 1905 . The action of optical isomers. II. Hyoscines . J Physiol , 32 : 510 – 510 .
   Google Scholar
• Senn , SJ and Richardson , W. 1994 . The first t-test . Stat Med , 13 : 785 – 803 .
   PubMed Web of Science ®Google Scholar
• 1908 . Student The probable error of a mean . Biometrika , 6 : 1 – 25 .
   Web of Science ®Google Scholar
• Fisher , RA . 1990 . “ Reprinted in Statistical Methods, Experimental Design and Scientific Inference ” . In Statistical Methods for Research Workers, 1925 , Edited by: Bennett , H. Oxford : Oxford University Press .
   Google Scholar
• Simpson , TW . 1938 . Experimental methods and human nutrition . J R Stat Soc B , 5 : 46 – 69 .
   Google Scholar
• Yates , F. 1938 . The gain in efficiency resulting from the use of balanced designs . J R Stat Soc B , 5 : 70 – 74 .
   Google Scholar
• Marks , HP . 1925 . The biological assay of insulin preparations in comparison with a stable standard . BMJ , 12 December : 1102 – 1104 .
   Google Scholar
• Irwin , JO . 1937 . Statistical method applied to biological assays . Supp J R Stat Soc IV , 12 December : 1 – 48 .
   Google Scholar
• Fieller , MA . 1940 . The biological standardization of insulin . Supp J R Stat Soc VII , 12 December : 1 – 64 .
   Google Scholar
• Finney , DJ . 1956 . Cross-over designs in bioassay . Proc R Soc B , 145 December : 42 – 60 .
   Web of Science ®Google Scholar
• Chassan , JB . 1964 . On the analysis of simple cross-overs with unequal numbers of replicates . Biomet-rics , 20 December : 206 – 208 .
   Web of Science ®Google Scholar
• Grizzle , JE and Grieve , AP . 1965, 1974,1982 . The two-period change-over design and its use in clinical trials . Biometrics , 21, 30,38 December : 467, 727,517 – 480 . Corrections see Grizzle JE:Correction to Grizzle The two-period changeover design in clinical trials
   Web of Science ®Google Scholar
• Hills , M. and Armitage , P. 1979 . The two-period cross-over trial . Br J Clin Pharmacol , 8 December : 7 – 20 .
   PubMed Web of Science ®Google Scholar
• Grieve , AP . 1985 . A Bayesian analysis of the two-period cross-over trial . Biometrics , 41 December : 979 – 990 .
   PubMed Web of Science ®Google Scholar
• Freeman , PR . 1989 . The performance of the two-stage analysis of two-treatment, two-period cross-over trials . Stat Med , 8 December : 1421 – 1432 .
   PubMed Web of Science ®Google Scholar
• Kershner , RP and Federer , WT . 1981 . Two-treatment cross-over designs for estimating a variety of effects . J Am Stat Assoc , 76 December : 612 – 619 .
   Web of Science ®Google Scholar
• Lasker , EM , Meisner , M. and Kushner , HB . 1983 . Optimal crossover designs in the presence of carryover effects . Biometrics , 39 December : 1089 – 1091 .
   Google Scholar
• Bishop , SH and Jones , BA . 1984 . Review of higher order cross-over trials . J Appl Stat , 11 December : 29 – 49 .
   Google Scholar
• Matthews , J. 1989 . Optimal cross-over designs for the comparison of two treatments in the presence of carry-over effects and autocorrelated errors . Biometrika , 74 December : 311 – 320 .
   Web of Science ®Google Scholar
• Matthews , J. 1994 . Multi-period cross-over trials . Stat Methods Med Res , 3 December : 383 – 405 .
   PubMedGoogle Scholar
• Fleiss , JL . 1986 . Letter to the editor . Biometrics , 42 December : 449 – 450 .
   PubMed Web of Science ®Google Scholar
• Fleiss , JL . 1989 . A critique of recent research on the two treatment cross-over design . Control Clin Trials , 10 December : 237 – 243 .
   PubMedGoogle Scholar
• Sheiner , LB , Hasimoto , Y. and Beal , SL . 1991 . A simulation study comparing studies for dose ranging . Stat Med , 10 December : 303 – 322 .
   PubMed Web of Science ®Google Scholar
• Senn , SJ . 1992 . Is the simple carry-over model useful? . Stat Med , 11 December : 715 – 726 .
   PubMed Web of Science ®Google Scholar
• Kunert , J. 1987 . Nearest neighbour designs for correlated errors . Biometrika , 74 December : 717 – 724 .
   Google Scholar
• Deheuvals , P. and Derzko , G. 1991 . Block designs for early-stage clinical trials . International Society for Clinical Biostatistics Conference . 1991 .
   Google Scholar
• Chi , EM . 1993 . Analysis of cross-over trials when within-subject errors follow an AR(1) process . Biomed J , 34 : 359 – 365 .
   Google Scholar
• Senn , SJ and Hildebrand , H. 1991 . Cross-over trials, degrees of freedom, the carry-over effect and its dual . Stat Med , 10 : 303 – 322 .
   PubMedGoogle Scholar
• Preece , DA . 1982 . T is for trouble (and textbooks): a critique of some examples of the paired-samples t-test . Statistician , 31 : 169 – 195 .
   Google Scholar
• Senn , SJ . 1994 . The AB/BA crossover: past, present and future? . Stat Methods Med Res , 3 : 303 – 324 .
   PubMedGoogle Scholar
• Graff-Lonnevig , V. and Browaldh , L. 1990 . Twelve hours bronchodilating effect of inhaled formoterol in children with asthma: a double-blind cross-over study versus salbutamol . Clin Exp Allergy , 20 : 429 – 432 .
   PubMed Web of Science ®Google Scholar
• Sheiner , LB . 1991 . The intellectual health of clinical drug evaluation . Clin Pharmacol Ther , 50 : 4 – 9 .
   PubMed Web of Science ®Google Scholar
• Balaam , LN . 1968 . A two period design with t 2 experimental units . Biometrics , 24 : 61 – 73 .
   PubMed Web of Science ®Google Scholar
• Patel , HI . 1983 . The use of baseline measurements in the two-period cross-over design . Commun Stat (A) , 12 : 2693 – 2721 .
   Web of Science ®Google Scholar
• Kenward , MG and Jones , B. 1987 . The analysis of data from 2 × 2 cross-over trials with baseline measure-ments . Stat Med , 6 : 911 – 926 .
   PubMed Web of Science ®Google Scholar
• Ratkowsky , DA , Evans , MA and Alldredge , JR . 1993 . Cross-over Experiments, Design, Analysis and Ap-plication , New York : Marcel Dekker .
   Google Scholar
• Grieve , AP . 1994 . Extending a Bayesian analysis of the two-period crossover to allow for baseline measurements . Stat Med , 13 : 905 – 929 .
   PubMed Web of Science ®Google Scholar
• Jones , BJ and Lewis , J. 1995 . The case for cross-over trials in phase III . Stat Med , 14 : 1025 – 1038 .
   PubMed Web of Science ®Google Scholar
• Senn , SJ . 1991 . Problems with the two stage analysis of cross-over trials . Br J Clin Pharmacol , 32 : 133
   PubMed Web of Science ®Google Scholar
• Senn , SJ . 1996 . “ The AB/BA cross-over: How to perform the two-stage analysis if you can't be persuaded that you shouldn't ” . In Liber Amicorum Roel van Strik , Edited by: Hansen and deRidder . Erasmus University .
   Google Scholar
• Deutsch , RI , Tashkin , DP and Simmons , M. 1980 . Bronchodilator effects of low doses of oral theo-phylline and terbutaline in asthmatic subjects . Ann Allergy , 45 : 137 – 143 .
   PubMedGoogle Scholar
• Hill , AV . 1910 . The possible effects of the aggregation of the molecules of haemoglobin on its disso-ciation curves . Proc Physiol Soc , 40 : 4 – 7 .
   Google Scholar
• Healy , M. 1991 . Stat Med , 10 : 899
   Google Scholar
• Box , GEP and Tiao , GC . 1973 . Bayesian Inference in Statistical Analysis , New York : Addison-Wesley .
   Google Scholar
• Grieve , AP . 1994 . Bayesian analyses of two-treatment crossover studies . Stat Methods Med Res , 3 : 407 – 429 .
   PubMedGoogle Scholar
• Draper , D. 1995 . Assessment and propagation of model uncertainty . J R Stat Soc B , 57 : 45 – 97 . (with discussion)
   Google Scholar
• Chatfield , C. 1995 . Model uncertainty, data mining and statistical inference . J R Stat Soc A , 158 : 419 – 466 . (with discussion)
   Web of Science ®Google Scholar
• Selwyn , MR , Dempster , AP and Hall , NR . 1981 . A Bayesian approach to bioequivalence for the 2 × 2 changeover . Biometrics , 37 : 11 – 21 .
   PubMed Web of Science ®Google Scholar
• Geisser , S. 1964 . Estimation in the uniform covariance case . J R Stat Soc B , 26 : 477 – 483 .
   Google Scholar
• Patil , VM . 1965 . Approximation to the Behrens-Fisher distributions . Biometrika , 52 : 267 – 271 .
   PubMed Web of Science ®Google Scholar
• Racine , A. , Grieve , AP , Flühler , H. and Smith , AFM . 1986 . Bayesian methods in practice: Experiences in the pharmaceutical industry . Appl Stat , 35 : 93 – 150 . (with discussion)
   Web of Science ®Google Scholar
• Spiegelhalter , DJ and Smith , AFM . 1982 . Bayes factors for linear and log-linear models with vague prior information . J R Stat Soc B , 44 : 377 – 387 .
   Google Scholar
• O'Hagan , A. 1995 . Fractional Bayes factors for model comparison . J R Stat Soc B , 57 : 99 – 138 . (with discussion)
   Google Scholar
• Grieve , AP . 1990 . “ Crossover versus parallel designs ” . In Statistical Methodology in the Pharmaceutical Sciences , Edited by: Berry , DA . New York : Marcel Dekker .
   Google Scholar
• Grieve , AP . 1995 . In discussion of Draper .
   Google Scholar
• Spiegelhalter , D. 1986 . In discussion of Racine .
   Google Scholar
• Wheatley , D. 1987 . Transdermal nitroglycerin in angina pectoris . Stress Med , 3 : 199 – 203 .
   Google Scholar
• Hews , RJ . 1981 . Further note on the interpretation of results from the two-period cross-over trial . Stat Pharmaceutical Indust Newsletter , 3
   Google Scholar
• Dawid , AP , Stone , M. and Zidek , JV . 1981 . Marginalisation paradoxes in Bayesian and structural inference . J R Stat Soc B , 35 : 189 – 233 . (with discussion)
   Google Scholar
• Smith , AFM and Spiegelhalter , DJ . 1981 . “ Bayesian approaches to multivariate structure ” . In Interpreting Multivariate Data , Edited by: Barnett , V. New York : Wiley .
   Google Scholar
• Senn , SJ . 1995 . Some controversies in designing and analysing cross-over trials . Biocybernet Biomed Ene , 15 : 27 – 39 .
   Google Scholar